Laboratory of Veterinary Parasitology, Department of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan, Musashino, Tokyo 180-8602, Japan.
Parasitol Res. 2013 Feb;112(2):655-63. doi: 10.1007/s00436-012-3182-5. Epub 2012 Nov 15.
Neospora caninum is an obligate intracellular protozoan parasite that causes severe neuromuscular diseases, repeated abortion, stillbirth, and congenital infection in livestock and companion animals. The development of an effective vaccine against neosporosis in cattle is an important issue due to the significant worldwide economic impact of this disease. We evaluated the immunogenicity of four bradyzoite antigens, NcBAG1 (first described in this study), NcBSR4, NcMAG1, and NcSAG4, using an acute infection mouse model to determine synergistic effects with the tachyzoite antigen as a candidate for vaccine production. Mice were inoculated with the recombinant vaccines (r-)NcBAG1, rNcBSR4, rNcMAG1, rNcSAG4, or phosphate-buffered saline (PBS) (adjuvant control group) in an oil-in-water emulsion with bitter gourd extract, a Th1 immune stimulator, or PBS alone as the infection control group. Mice inoculated with each vaccine developed antigen-specific IgG1 and IgG2a antibodies and isolated splenocytes from mice produced high levels of interferon-γ when infected with the N. caninum tachyzoite. The mice inoculated with rNcBAG1, rNcMAG1, or rNcSAG4 developed slight to moderate clinical symptoms but did not succumb to infection. In contrast, rNcBSR4 and both control groups developed severe disease and some mice required euthanasia. The parasitic burden in the brain tissues of vaccinated mice was assessed by N. caninum-specific real-time PCR at 5 weeks after infection. The parasite load in rNcBAG1-, rNcMAG1-, and rNcSAG4-inoculated mice was significantly lower than that in adjuvant and infection control mice. Therefore, these antigens may be useful for the production of a N. caninum-specific vaccination protocol.
刚地弓形虫是一种专性细胞内原生动物寄生虫,可引起家畜和伴侣动物严重的神经肌肉疾病、反复流产、死产和先天性感染。由于这种疾病在全球范围内造成了重大的经济影响,因此开发一种针对牛刚地弓形虫的有效疫苗是一个重要问题。我们使用急性感染小鼠模型评估了四种缓殖子抗原(NcBAG1、NcBSR4、NcMAG1 和 NcSAG4)的免疫原性,以确定与速殖子抗原协同作用的效果,作为疫苗生产的候选抗原。在油包水乳液中,用苦瓜提取物(Th1 免疫刺激剂)或单独的磷酸盐缓冲盐水(PBS,佐剂对照组)将重组疫苗(r-)NcBAG1、rNcBSR4、rNcMAG1、rNcSAG4 或 PBS 接种到感染控制组的小鼠中。用每种疫苗接种的小鼠均产生了针对抗原的 IgG1 和 IgG2a 抗体,并且从感染 N. caninum 速殖子的小鼠中分离出的脾细胞产生了高水平的干扰素-γ。接种 rNcBAG1、rNcMAG1 或 rNcSAG4 的小鼠出现轻微至中度临床症状,但未死于感染。相比之下,rNcBSR4 和两个对照组出现严重疾病,一些小鼠需要安乐死。感染后 5 周,通过 N. caninum 特异性实时 PCR 评估接种疫苗小鼠脑组织中的寄生虫负担。rNcBAG1、rNcMAG1 和 rNcSAG4 接种小鼠的寄生虫负荷明显低于佐剂和感染对照组小鼠。因此,这些抗原可能有助于生产针对刚地弓形虫的疫苗方案。